Hepatitis C Combination Therapy - The Hepatoprotective Effect of Liv.52 in Cirrhotic Patients

The Hepatoprotective Effect of Liv.52 in Cirrhotic Patients
An Iranian research study recently concluded that the herbal components of Liv.52 are beneficial in the treatment of cirrhotic patients. The six-month randomized, double-blind study demonstrated that patients treated with Liv.52 showed better test results than those treated with placebo....

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...

Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005